Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
about
L-asparaginase in the treatment of patients with acute lymphoblastic leukemiaAsparaginase pharmacokinetics and implications of therapeutic drug monitoringHow to manage asparaginase hypersensitivity in acute lymphoblastic leukemiaPharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginaseThe best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.Erwinia asparaginase in pediatric acute lymphoblastic leukemia.Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia.Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia.Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia.A cost analysis of individualized asparaginase treatment in pediatric acute lymphoblastic leukemia.Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.Personalized nanomedicine: a rapid, sensitive, and selective UV-vis spectrophotometry method for the quantification of nanostructured PEG-asparaginase activity in children's plasma
P2860
Q26738640-4FF9FBC4-D71B-4C6E-9058-015F6403B38AQ27026476-57B8F350-BA91-4841-9C82-224046B80EE8Q27026952-3A782E73-9EA4-4D44-9080-30C0FD347B74Q34221738-BAAE9455-5521-4500-9246-6C551F6A68ADQ34400424-FCB000D8-BA71-42E9-A428-2EF2736FA173Q35732108-237652F2-3720-472E-B70D-740D708C6DFAQ36762608-521F2B4D-3930-47B6-B9F9-67D84866CC4EQ37670065-E5BA07E1-3E45-4388-8777-75EE73A9B149Q38040418-49B7EDC6-7746-43D8-8869-1644731BC883Q38248280-16C63C34-E49D-4ABB-A6E1-0FB08858D7E9Q38696311-36CD5A84-9199-4587-988F-356EF50E78A1Q38933372-5B48FFCB-325E-46B3-B897-B70B633AD28AQ40243523-CBA2E33C-4546-467C-A7C2-CC4F84416A67Q43025556-D71A69EE-20C1-421F-93EE-284F5459556FQ48166631-0B79B52E-3223-409C-AF58-C93C41441994Q48306936-CCA76BE9-C6E0-4938-B4A5-052FE8656D34Q53633913-7A587829-F9C1-4296-A24E-98C41A3CDD9BQ58563335-73E45CFF-0C9E-410A-8199-978B1E342BA9
P2860
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@ast
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@en
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@nl
type
label
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@ast
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@en
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@nl
prefLabel
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@ast
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@en
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@nl
P2093
P2860
P3181
P1476
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries
@en
P2093
B K Albertsen
H J Müller
H Schrøder
K Schmiegelow
N T Carlsen
P Jakobsen
P2860
P3181
P356
10.1046/J.0306-5251.2001.01464.X
P407
P577
2001-10-01T00:00:00Z